IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.692
AS - Asia 12.936
EU - Europa 11.633
SA - Sud America 2.806
AF - Africa 336
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 30
Totale 48.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.528
SG - Singapore 4.746
RU - Federazione Russa 3.453
CN - Cina 3.105
IT - Italia 2.677
BR - Brasile 2.204
VN - Vietnam 1.807
GB - Regno Unito 1.763
HK - Hong Kong 918
BD - Bangladesh 897
DE - Germania 841
CA - Canada 824
UA - Ucraina 625
FR - Francia 435
SE - Svezia 317
IN - India 274
FI - Finlandia 272
DK - Danimarca 271
AR - Argentina 224
NL - Olanda 223
MX - Messico 218
IE - Irlanda 190
IL - Israele 177
PL - Polonia 177
TR - Turchia 160
ID - Indonesia 132
EC - Ecuador 123
ES - Italia 112
JP - Giappone 112
PK - Pakistan 111
IQ - Iraq 108
ZA - Sudafrica 107
AT - Austria 70
MA - Marocco 62
UZ - Uzbekistan 60
CO - Colombia 59
VE - Venezuela 53
AE - Emirati Arabi Uniti 43
CL - Cile 42
LT - Lituania 41
PH - Filippine 36
PY - Paraguay 33
SA - Arabia Saudita 32
KE - Kenya 31
MY - Malesia 30
TN - Tunisia 28
EG - Egitto 27
EU - Europa 27
NP - Nepal 25
PE - Perù 24
UY - Uruguay 23
CH - Svizzera 21
RO - Romania 21
HN - Honduras 20
BE - Belgio 18
DZ - Algeria 18
AU - Australia 17
JM - Giamaica 17
JO - Giordania 17
AZ - Azerbaigian 16
CR - Costa Rica 14
TH - Thailandia 14
KG - Kirghizistan 13
KR - Corea 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
GR - Grecia 12
PS - Palestinian Territory 12
NI - Nicaragua 11
PT - Portogallo 11
CZ - Repubblica Ceca 10
NZ - Nuova Zelanda 9
PA - Panama 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
BG - Bulgaria 7
ET - Etiopia 7
GT - Guatemala 7
HU - Ungheria 7
KZ - Kazakistan 7
LY - Libia 7
OM - Oman 7
SI - Slovenia 7
AO - Angola 6
BH - Bahrain 6
CI - Costa d'Avorio 6
GE - Georgia 6
IR - Iran 6
MG - Madagascar 6
QA - Qatar 6
AL - Albania 5
CG - Congo 5
GY - Guiana 5
HR - Croazia 5
MT - Malta 5
NO - Norvegia 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
Totale 48.360
Salva come PNG Salva come JPEG
Città #
Dallas 3.740
Singapore 2.378
Ashburn 1.507
San Jose 1.350
Beijing 1.238
Southend 907
Hong Kong 799
Chandler 734
Los Angeles 636
Moscow 597
Fairfield 585
Houston 548
Ho Chi Minh City 540
Woodbridge 469
Chicago 444
San Mateo 436
New York 426
Ann Arbor 422
Falls Church 406
Milan 397
Seattle 369
Hanoi 362
Cambridge 333
Jacksonville 331
Wilmington 323
The Dalles 309
Rome 275
Ottawa 257
Buffalo 248
Santa Clara 248
São Paulo 234
Boardman 226
Lauterbourg 224
Hefei 216
Dearborn 214
Dublin 188
Pisa 180
Salt Lake City 178
Portsmouth 170
Stevenage 164
Beauharnois 163
Council Bluffs 162
Orem 156
Tel Aviv 154
Warsaw 154
Munich 149
Dong Ket 147
Helsinki 142
London 140
Lawrence 132
Montreal 130
Brooklyn 120
Mexico City 111
Tokyo 99
Denver 98
Atlanta 93
Stockholm 92
Frankfurt am Main 88
Poplar 87
Chennai 85
Tampa 84
Toronto 82
Istanbul 77
Amsterdam 75
Florence 75
Johannesburg 73
Da Nang 72
Elk Grove Village 72
Montréal 72
Rio de Janeiro 71
Phoenix 68
Nuremberg 66
San Diego 64
Figino 63
Haiphong 62
Boston 57
Tashkent 55
Fremont 53
San Francisco 52
Manchester 49
Guayaquil 48
Ankara 47
Columbus 47
Biên Hòa 45
Bologna 44
Turku 44
Genoa 43
Mumbai 43
Naples 43
Turin 43
Brasília 41
Lappeenranta 40
Redwood City 40
Belo Horizonte 39
Paris 37
Dongguan 36
Guangzhou 36
Baghdad 35
Curitiba 35
Lancaster 34
Totale 28.272
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.703
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 595
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 506
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 450
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 397
A simple echocardiographic score to rule out cardiac amyloidosis 387
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 356
A simple echocardiographic score to rule out cardiac amyloidosis 354
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 348
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 344
Central sleep apnea and cardiovascular disease state-of-the-art 340
[Central apneas and cardiovascular diseases] 333
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 332
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 330
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 325
Treating chemoreflex in heart failure: modulation or demolition? 324
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 324
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 324
Prediction of the chemoreflex gain by common clinical variables in heart failure 323
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 315
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 314
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 314
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 311
Adrenergic activation in heart failure: blockade or rebalance? 309
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 304
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 303
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 299
Eligibility for vericiguat in a real‐world, contemporary heart failure population 297
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 297
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 296
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 295
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 293
Screening the health status of people working in a university 289
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 289
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 282
How to take arms against central apneas in heart failure 281
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 280
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 280
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 279
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 278
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 277
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 272
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 268
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 268
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 268
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 266
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 264
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 262
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 261
B-type natriuretic peptide secretion following scuba diving 260
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 260
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 259
null 258
Valve disease in cardiac amyloidosis: an echocardiographic score 258
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 258
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 258
null 258
Improved survival in limited scleroderma-related pulmonary artery hypertension 257
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 255
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 254
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 253
null 253
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 252
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 251
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 250
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 250
A Novel Workflow for Electrophysiology Studies in Patients with Brugada Syndrome 247
An atypical case of cardiac amyloidosis. 247
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 247
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 247
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 245
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 241
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 241
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 240
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 240
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 239
Etiology, clinical presentation, and management of left main coronary artery aneurysms 237
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 237
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 237
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 236
Role of Imaging in Cardiomyopathies 235
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing 235
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 234
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 234
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 234
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 231
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 231
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 230
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 230
Renin profiling predicts neurohormonal response to sacubitril/valsartan 230
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 229
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 228
null 228
A scoping review of machine learning models to predict risk of falls in elders, without using sensor data 227
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 227
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 226
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 226
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 225
Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction 224
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 224
Totale 29.319
Salva come PNG Salva come JPEG
Categoria #
all - tutte 232.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 232.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 0 0 0 0 0 0 456
2021/20222.330 146 385 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.696 65 80 466 207 596 585 1.383 2.351 871 949 1.993 1.150
2025/202625.954 1.363 4.006 2.931 3.638 2.944 1.612 2.391 1.058 1.413 1.557 1.726 1.315
Totale 48.732